Breast Cancer With Over-expression of erbB2-BRAINSTORM
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Cancer
Interventions: DRUG: Anti-erbB2 therapy as part of a treatment regimen for either brain metastases or primary breast cancer
Sponsor: GlaxoSmithKline